Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Sky One's Leaders Aim To Derail Potential Shareholders' Suit Headed By California Law Firm

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Just weeks after alleging that U.S. media reports constituted "reckless criticism and attacks" for suggesting that China Sky One Medical misreported earnings, the Chinese firm has now confirmed that it filed inaccurate revenue statements with Chinese commercial authorities

You may also be interested in...



Facing Potential Shareholder Suit And SEC Inquiry In U.S., China Sky One Medical Tries To Reassure Investors

BEIJING - While facing a potential shareholders' suit for possible violation of U.S. laws, the leadership of China Sky One Medical Inc. sought to reassure investors by disclosing a rise in earnings for 2010 and inviting investors to visit the firm's headquarters in Harbin, an ice-covered Chinese city that borders Russia's Siberia

Facing Potential Shareholder Suit And SEC Inquiry In U.S., China Sky One Medical Tries To Reassure Investors

BEIJING - While facing a potential shareholders' suit for possible violation of U.S. laws, the leadership of China Sky One Medical Inc. sought to reassure investors by disclosing a rise in earnings for 2010 and inviting investors to visit the firm's headquarters in Harbin, an ice-covered Chinese city that borders Russia's Siberia

China Sky One Blames U.S. Media Reports For Driving Down NASDAQ Share Price

BEIJING - Just months after threatening to sue an American shareholder for posting negative reports about China Sky One Medical on a U.S. Web site, the leadership of NASDAQ-traded Sky One has issued a new public declaration that unfavorable media reports about the firm that have been driving down its share price are unfounded and reckless

Latest Headlines
See All
UsernamePublicRestriction

Register

SC077217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel